-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cytosorbents Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Cytosorbents Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.4M, a 40.2% increase year-over-year.
- Cytosorbents Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$22.1M, a 21.3% increase year-over-year.
- Cytosorbents Corp annual Operating Income (Loss) for 2023 was -$31.2M, a 0.99% increase from 2022.
- Cytosorbents Corp annual Operating Income (Loss) for 2022 was -$31.5M, a 38.6% decline from 2021.
- Cytosorbents Corp annual Operating Income (Loss) for 2021 was -$22.7M, a 119% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)